STARWOOD-HOTELS
12.5.2014 09:01:55 CEST | Business Wire | Pressemeddelelse
Starwood Hotels & Resorts Worldwide, Inc. (NYSE:HOT) today announced that the internationally-renowned Excelsior Hotel Gallia in Milan will join The Luxury Collection® portfolio. Owned by Katara Hospitality, Excelsior Hotel Gallia, a Luxury Collection Hotel, Milan will open this November following an extensive renovation. The opening will mark The Luxury Collection’s seventh hotel in Italy, as the brand remains on track to surpass 100 hotels globally in the next five years.
“I would like to thank Katara Hospitality for putting their trust in Starwood as we extend our partnership to bring The Luxury Collection brand to Milan,” said Michael Wale, President, Starwood Hotels & Resorts, Europe, Africa and Middle East. “With the brand’s origin in Italy, we are delighted to open this newly renovated hotel in Milan. Historic architectural gems such as Excelsior Hotel Gallia are perfectly suited to The Luxury Collection brand, which offers authentic travel experiences and exceptional service for global explorers and the local community.”
“We always embrace the local spirit wherever we invest in hotel assets around the world and the Excelsior Hotel Gallia in Milan is no exception,” said Sheikh Nawaf Bin Jassim Bin Jabor Al Thani, Chairman, Katara Hospitality. “We have made a major investment to bring this grand property back to its true glory. Today, it gives us great pleasure to share our Italian flagship property with Starwood Hotels & Resorts.”
Hamad Abdulla Al Mulla, Chief Executive Officer, Katara Hospitality added, “We are confident the ethos of The Luxury Collection brand is a strategic fit for our hotel as it is important that we have an operator which understands and respects the heritage of this wonderful hotel, ensuring it occupies its rightful position in the Italian and global market-places when it re-opens later this year.”
Located in the Piazza Duca d’Aosta, Excelsior Hotel Gallia opened in 1932 in central Milan as one of the city’s most prestigious hotels. Now undergoing a meticulous renovation and strategic expansion, the hotel will return its original grandeur where Milan’s most fashionable mix and mingle. Marrying contemporary design with the Belle Époque architectural style, the hotel’s new architecture and design concept - led by Studio Marco Piva - has already won an Italian tourism industry award *, recognising its outstanding combination of historical and contemporary elements.
The hotel will offer 235 elegant guest rooms and suites, a signature restaurant and a roof-top bar with panoramic views of the city, an elegant lounge bar and cigar room, plus 1,000 square metres of wellness facilities including a spa, indoor swimming pool and fitness centre. Excelsior Hotel Gallia will also offer unparalleled event and meeting spaces for special celebrations including a congress centre spanning more than 1,000 square metres and comprising two ballrooms, six meeting rooms and a business centre.
“As an established market, Italy offers exceptional potential to expand our presence across all brands, especially in the luxury sector,” said Bart Carnahan, Senior Vice President Acquisition & Development, Starwood Hotels & Resorts, Europe, Africa & Middle East. “The iconic Excelsior Hotel Gallia joins other historic landmark Luxury Collection hotels in Italy, in Venice and Naples as well as exceptional resorts in Costa Smeralda in Sardinia.”
Starwood currently has 21 hotels in Italy, representing five of its lifestyle brands – St. Regis, The Luxury Collection, Sheraton, Westin and Four Points by Sheraton. In Milan, the company is represented by The Westin Palace, Sheraton Diana Majestic, Sheraton Milan Malpensa Airport Hotel & Conference Centre and Four Points by Sheraton Milan, and is set to launch W Milan in 2016. Last year, The Luxury Collection restored and reopened The Gritti Palace in Venice, enhanced the public spaces and guest accommodations including the addition of unique suites at Hotel Danieli in Venice and introduced new villas to Hotel Pitrizza and Hotel Romazzino in Costa Smeralda in Sardinia.
Katara Hospitality is a global hotel owner, developer and operator with a collection of iconic hotels in key markets across Europe, Africa and Asia.
*The “Tourism for Italy” award in the “New Hospitality Structures” category was announced at the Expo Italia Real Estate exhibition in Milan and accepted by Studio Marco Piva, the architecture and design firm overseeing the hotel refurbishment.
No. No. No.
About The Luxury Collection Hotels & Resorts
The Luxury
Collection® is an ensemble of hotels and resorts offering unique,
authentic experiences that evoke lasting, treasured memories. For the
global explorer, The Luxury Collection offers a gateway to the world's
most exciting and desirable destinations. Each hotel and resort is a
unique and cherished expression of its location; a portal to the
destination's indigenous charms and treasures. Magnificent decor,
spectacular settings, impeccable service and the latest modern
conveniences combine to provide a uniquely enriching experience.
Originated in 1906 under the CIGA brand as a collection of Europe's most
celebrated and iconic properties, today The Luxury Collection brand is a
glittering ensemble of more than 85 of the world's finest hotels and
resorts in more than 30 countries in bustling cities and spectacular
destinations around the world. The Luxury Collection includes
award-winning properties that continuously exceed guest expectations by
offering unparalleled service, style and class while celebrating each
hotel's distinctive heritage and unique character. All of these hotels,
many of them centuries old, are internationally recognized as being
among the world's finest. For more information, please visit www.luxurycollection.com
About Katara Hospitality
Katara Hospitality is a global
hotel owner, developer and operator, based in Qatar. With over 40 years’
experience in the industry, Katara Hospitality actively pursues its
strategic expansion plans by investing in peerless hotels in Qatar while
growing its collection of iconic properties in key international
markets. Katara Hospitality has set a target of owning and / or managing
30 hotels by 2016 and 30 more over the following decade. Aiming to
become one of the leading hospitality organisations in the world, the
company is supporting Qatar’s long term economic vision. Katara
Hospitality currently owns properties spread across three continents, in
Qatar, Singapore, The Maldives, Switzerland, France, Italy, Egypt,
Morocco, The Gambia and the Union of Comoros. While partnering with some
of the finest hotel operators, Katara Hospitality also owns its own
operator brands: The Bürgenstock Selection and Merweb Hotels.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140512005079/en/
Contact:
Starwood Hotels & Resorts
Angelina Hue, Tel. +32 2 204
5518
Manager Brand Communications & Events – Europe, Africa &
Middle East
angelina.hue@starwoodhotels.com
www.starwoodmediacentre.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Netceed Strengthens Board with Global Infrastructure and Technology Leaders1.4.2026 14:00:00 CEST | Press release
Netceed, a global leader in delivering supply chain solutions across broadband, data center and energy infrastructure, today announced the appointment of Franck Bruel, Jan Frykhammar and Stacey Thompson to advise as strategic advisors to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401045867/en/ Franck Bruel Following the recently announced recapitalization of the Netceed Group and under the chairmanship of Rajeev Suri, the company is strengthening its Board with globally recognized leaders across telecommunications infrastructure, industrial distribution, energy infrastructure and hyperscale technology. Collectively, the new appointees bring decades of leadership experience across some of the world’s most influential infrastructure and technology companies, reflecting Netceed’s ambition to play a leading role in the next generation of global digital, AI and energy infrastructure. Rajeev Suri, Ch
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press release
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant in the CFTR protein--Approximately 800 more people with CF in the US are now eligible for a CFTR modulator for the first time- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported b
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press release
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer CasesColorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooper
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum